Letters archive
Join the conversation in New Scientist's Letters section, where readers can share their thoughts and opinions on articles and see responses from experts and enthusiasts across a range of science topics. To submit a letter, please see our terms and email letters@newscientist.com
17 October 2012
From Stephen Whitehead, Chief executive, Association of the British Pharmaceutical Industry
Ben Goldacre, the author of Bad Pharma , seems fixated on issues within the pharmaceutical industry which have long been addressed (6 October, p 28) . He claims that "drugs are tested in poorly designed studies... selectively reported, with unflattering data hidden". In the UK there is a robust system of regulation for the undertaking …
17 October 2012
From Chuck Stewart, Director of the Lesbian and Gay Psychotherapy Association of Southern California
It is about time that the US outlawed the ineffective and unethical psychological practices of "conversion" or "reparative" therapies (6 October, p 7) . They have never worked and are disrespectful to people who are lesbian, gay, bisexual or who are questioning their sexuality. California has done the right thing in banning those therapies. Now, …